echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Science Sub-Journal: Human Orthogonal IL-2/IL-2Rβ System Enhances the Proliferation and Antitumor Effects of CAR-T Cells

    Science Sub-Journal: Human Orthogonal IL-2/IL-2Rβ System Enhances the Proliferation and Antitumor Effects of CAR-T Cells

    • Last Update: 2022-04-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    March 8, 2022 / Bio Valley BIOON/--- Interleukin-2 (IL-2) is a crucial T cell cytokine that promotes T cell proliferation and effector function, and is considered a therapeutic a method for cancer; however, systemic administration of IL-2 often results in severe toxic side effects, which limits its application in enhancing CAR-T cell immunotherapy


    In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania and the Stanford University School of Medicine designed a pair of human orthogonal IL-2 (ortho-hIL-2) and human Orthogonal IL-2Rβ (ortho-hIL-2Rβ) pair containing human-specific mutations


    T cells, image via CC0 Public Domain


    T cells are genetically engineered to express the receptor ortho-hIL-2Rβ, which can only be activated by ortho-hIL-2


    Using CAR-T cells that specifically target CD19, these authors found that ortho-hIL-2 induced ortho-hIL-2Rβ-positive CAR-T cells 2 weeks after adoptive transfer into immunodeficient mice bearing CD19+ Nalm6 leukemia xenografts Dose-dependent increase of T cell proliferation in vivo by up to 1000-fold


    Ortho-hIL-2 can rescue the anti-leukemia effect of an unsatisfactory CAR-T cell dose


    References:

    Qian Zhang et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.